相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Exposure measurement error when assessing current glucocorticoid use using UK primary care electronic prescription data
Rebecca M. Joseph et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2019)
Effect of cumulative exposure to corticosteroid and DMARD on radiographic progression in rheumatoid arthritis: results from the ESPOIR cohort
Baptiste Louveau et al.
RHEUMATOLOGY (2018)
Patterns of the initiation of disease-modifying antirheumatic drugs in incident rheumatoid arthritis: a German perspective based on nationwide ambulatory drug prescription data
Annika Steffen et al.
RHEUMATOLOGY INTERNATIONAL (2018)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Epidemiology and Treatment of New-Onset and Established Rheumatoid Arthritis in an Insured US Population
Martin M. Crane et al.
ARTHRITIS CARE & RESEARCH (2015)
Half of UK patients with rheumatoid arthritis are prescribed oral glucocorticoid therapy in primary care: a retrospective drug utilisation study
Rachel J. Black et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Risk factors of severe infections in patients with rheumatoid arthritis treated with leflunomide
Han-Gyul Yoo et al.
Modern Rheumatology (2014)
Rheumatoid arthritis pharmacotherapy and predictors of disease-modifying anti-rheumatic drug initiation in the early years of biologic use in Quebec, Canada
Jean-Pascal Roussy et al.
RHEUMATOLOGY INTERNATIONAL (2014)
Receipt of Glucocorticoid Monotherapy Among Medicare Beneficiaries With Rheumatoid Arthritis
Jinoos Yazdany et al.
ARTHRITIS CARE & RESEARCH (2014)
Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis
William G. Dixon et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs
Vivian P. Bykerk et al.
JOURNAL OF RHEUMATOLOGY (2012)
The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study
W. G. Dixon et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis
Diane Lacaille et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years - A multicenter, double-blind, placebo-controlled trial
S Wassenberg et al.
ARTHRITIS AND RHEUMATISM (2005)
Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate -: A two-year randomized trial
B Svensson et al.
ARTHRITIS AND RHEUMATISM (2005)
Gaps in care for rheumatoid arthritis: A population study
D Lacaille et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2005)
Attitude of rheumatoid arthritis patients to treatment with oral corticosteroids
E Morrison et al.
RHEUMATOLOGY (2003)
Quality of care for patients with rheumatoid arthritis
CH MacLean et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
